{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:54:51Z","timestamp":1791294891087,"version":"4.1.0"},"reference-count":24,"publisher":"American Diabetes Association","issue":"8","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:p>Studies that have compared HbA1c levels by race have consistently demonstrated higher HbA1c levels in African Americans than in whites. These racial differences in HbA1c have not been explained by measured differences in glycemia, sociodemographic factors, clinical factors, access to care, or quality of care. Recently, a number of nonglycemic factors and several genetic polymorphisms that operate through nonglycemic mechanisms have been associated with HbA1c. Their distributions across racial groups and their impact on hemoglobin glycation need to be systematically explored. Thus, on the basis of evidence for racial differences in HbA1c, current clinical guidelines from the American Diabetes Association state: \u201cIt is important to take\u2026race\/ethnicity\u2026into consideration when using the A1C to diagnose diabetes.\u201d However, it is not clear from the guidelines how this recommendation might be actualized. So, the critical question is not whether racial differences in HbA1c exist between African Americans and whites; the important question is whether the observed differences in HbA1c level are clinically meaningful. Therefore, given the current controversy, we provide a Point-Counterpoint debate on this issue. In the point narrative below, Dr. Herman provides his argument that the failure to acknowledge that HbA1c might be a biased measure of average glycemia and an unwillingness to rigorously investigate this hypothesis will slow scientific progress and has the potential to do great harm. In the counterpoint narrative that follows Dr. Herman\u2019s contribution, Dr. Selvin argues that there is no compelling evidence for racial differences in the validity of HbA1c as a measure of hyperglycemia and that race is a poor surrogate for differences in underlying causes of disease risk.<\/jats:p>\n               <jats:p>\u2014William T. Cefalu<\/jats:p>\n               <jats:p>Editor in Chief, Diabetes Care<\/jats:p>","DOI":"10.2337\/dc15-2686","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T13:23:01Z","timestamp":1469452981000},"page":"1458-1461","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":60,"title":["Are There Clinical Implications of Racial Differences in HbA1c? Yes, to Not Consider Can Do Great Harm!"],"prefix":"10.2337","volume":"39","author":[{"given":"William H.","family":"Herman","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Department of Epidemiology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"2022031301034846600_B1","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2337\/dc05-1973","article-title":"Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis","volume":"29","author":"Kirk","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B2","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc06-2003","article-title":"Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program","volume":"30","author":"Herman","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1464-5491.2006.02022.x","article-title":"A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of type 2 diabetic patients in North America and Europe","volume":"23","author":"Viberti","year":"2006","journal-title":"Diabet Med"},{"key":"2022031301034846600_B4","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1001\/archinte.167.17.1853","article-title":"Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the Health and Retirement Study","volume":"167","author":"Heisler","year":"2007","journal-title":"Arch Intern Med"},{"key":"2022031301034846600_B5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc07-1924","article-title":"Medication adherence and racial differences in A1C control","volume":"31","author":"Adams","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amepre.2006.12.011","article-title":"Trends in black-white differentials in dietary intakes of U.S. adults, 1971-2002","volume":"32","author":"Kant","year":"2007","journal-title":"Am J Prev Med"},{"key":"2022031301034846600_B7","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2337\/diacare.24.11.1911","article-title":"Fat consumption and HbA(1c) levels: the EPIC-Norfolk Study","volume":"24","author":"Harding","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11606-007-0502-z","article-title":"The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry","volume":"23","author":"Ahmed","year":"2008","journal-title":"J Gen Intern Med"},{"key":"2022031301034846600_B9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00125-013-3058-y","article-title":"HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis","volume":"57","author":"Soulimane","year":"2014","journal-title":"Diabetologia"},{"key":"2022031301034846600_B10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2350-13-30","article-title":"Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III)","volume":"13","author":"Grimsby","year":"2012","journal-title":"BMC Med Genet"},{"key":"2022031301034846600_B11","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.2337\/db10-0502","article-title":"Common variants at 10 genomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways","volume":"59","author":"Soranzo","year":"2010","journal-title":"Diabetes"},{"key":"2022031301034846600_B12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature13997","article-title":"The African Genome Variation Project shapes medical genetics in Africa","volume":"517","author":"Gurdasani","year":"2015","journal-title":"Nature"},{"key":"2022031301034846600_B13","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.2337\/db13-1815","article-title":"Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians","volume":"63","author":"Chen","year":"2014","journal-title":"Diabetes"},{"key":"2022031301034846600_B14","doi-asserted-by":"crossref","first-page":"e79767","DOI":"10.1371\/journal.pone.0079767","article-title":"A study assessing the association of glycated hemoglobin A1C (HbA1C) associated variants with HbA1C, chronic kidney disease and diabetic retinopathy in populations of Asian ancestry","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"2022031301034846600_B15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc12-0404","article-title":"No ethnic differences in the association of glycated hemoglobin with retinopathy: the National Health and Nutrition Examination Survey 2005-2008","volume":"36","author":"Bower","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B16","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2337\/dc12-2715","article-title":"No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes","volume":"36","author":"Selvin","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s00125-014-3190-3","article-title":"Sex differences in the risk of stroke and HbA(1c) among diabetic patients","volume":"57","author":"Zhao","year":"2014","journal-title":"Diabetologia"},{"key":"2022031301034846600_B18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2337\/dc13-1525","article-title":"HbA1c and coronary heart disease risk among diabetic patients","volume":"37","author":"Zhao","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.annepidem.2012.11.002","article-title":"Impact of diabetes control on mortality by race in a national cohort of veterans","volume":"23","author":"Hunt","year":"2013","journal-title":"Ann Epidemiol"},{"key":"2022031301034846600_B20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010","volume":"36","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B21","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.2337\/dc12-2711","article-title":"Ethnic differences in glycemic markers in patients with type 2 diabetes","volume":"36","author":"Wolffenbuttel","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B22","doi-asserted-by":"crossref","first-page":"b5444","DOI":"10.1136\/bmj.b5444","article-title":"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study","volume":"340","author":"Miller","year":"2010","journal-title":"BMJ"},{"key":"2022031301034846600_B23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2337\/dc07-1790","article-title":"Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005","volume":"31","author":"Ginde","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031301034846600_B24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","article-title":"National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011","volume":"174","author":"Lipska","year":"2014","journal-title":"JAMA Intern Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/8\/1458\/626111\/dc152686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/8\/1458\/626111\/dc152686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:39:51Z","timestamp":1647146391000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/8\/1458\/37142\/Are-There-Clinical-Implications-of-Racial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,7,12]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc15-2686","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]}}}